Crispo, Anna
Augustin, Livia S. A.
Luongo, Assunta
Calderaio, Claudia
Breda, Joao
Coluccia, Sergio
Calabrese, Alessandra
Marrazzo, Vittorio
Giannatiempo, Rosa
Trasacco, Paola
Palumbo, Elvira
Vitale, Sara
Porciello, Giuseppe
Di Gennaro, Piergiacomo
Caputo, Roberta
Buono, Giuseppe
Vernieri, Claudio
Schettini, Francesco
Grimaldi, Maria
Nocerino, Flavia
Celentano, Egidio
Amore, Alfonso
Giuliano, Mario
De Placido, Pietro
De Angelis, Carmine
Bianco, Roberto
De Laurentiis, Michelino
La Vecchia, Carlo
Arpino, Grazia
Article History
Received: 22 August 2023
Accepted: 19 October 2023
First Online: 1 December 2023
Competing interests
: MG reports Consulting fees from Honoraria Lilly, Celgene, Novartis, Pfizer, Astra Zeneca, Daiichi-Sankyo, MSD, Honoraria from Lilly, Celgene, Novartis, Pfizer, Istituto Gentili, Eisai Europe Ltd, Roche, Astra Zeneca, Daiichi-Sankyo, MSD, Gilead, travel accomodations from Novartis, Pfizer, Roche; LSAA is a founding member of the International Carbohydrate Quality Consortium (ICQC, ExternalRef removed), has received honoraria from the Nutrition Foundation of Italy (NFI, Milan), research grants for lifestyle studies from Lega Italiana per la Lotta contro i Tumori (LILT, Rome) a non-profit organization for the fight against cancer, and in-kind study support from Abiogen Pharma (Pisa, Italy), Barilla Spa (Parma, Italy), Roberto Alimentare (Treviso, Italy), Panificio Giacomo Luongo (Napoli, Italy), Consorzio Mandorle di Avola (Siracusa, Italy), SunRice (Australia) and Almond Board of California (USA); RC reports Honoraria from Novartis, Lilly, Astra Zeneca, Daichii Sankyo, Veracyte, Pfizer, has been Consulting/Advisor for Roche, Astra Zeneca, Lilly, Daichii Sankyo, Novartis, Seagen, MSD, Gilead, received research funding from Gilead, and travel accommodation from Lilly, Novartis; GB reports Honoraria or speakers’ fee from Novartis, GSK, Eli-Lilly, Pfizer, AstraZeneca, Roche, Daiichi Sankyo, Exact Science, Genetic.Spa; CV reports Advisory role for Novartis, Pfizer, Eli Lilly, Daiichi Sankyo, Consultancy for Eli Lilly, Honoraria as a speaker from Novartis, Pfizer, Eli Lilly, Istituto Gentili, Accademia di Medicina, Research grants from Roche; FS reports honoraria from Novartis, Gilead and Daiichy-Sankyo for educational events/materials and travel expenses from Novartis, Gilead and Daiichy-Sankyo; PDP reports Speaker’s Honoraria from Lilly, Gilead, MSD, Roche, Exact Sciences, Novartis, travel accommodations from Gilead, Lilly, Istituto Gentili, Roche; CDA reports Honoraria from Novartis, Lilly, Seagen, Pfizer, Astra Zeneca, Advisory role for Lilly, GSK, Novartis, travel accomodations from Gilead and Pfizer, research grants from Novartis; RB reports Honoraria from Roche, Astra Zeneca, Novartis, Lilly, BMS, MSD, Pfizer, Advisory role for Roche, Astra Zeneca, Novartis, Lilly, BMS, MSD, Pfizer, research Investigator Grant from AIRC; MDL reports personal fees as Speaker’s and Advisory Board Honoraria from Pfizer, Novartis, Roche, Astra Zeneca, Eisai, Eli Lilly, MSD, Pierre Fabre; GA reports Consulting fees from Roche, Astra Zeneca, Novartis, Lilly, MSD, Pfizer, Honoraria from Roche, Astra Zeneca, Novartis, Lilly, MSD, Pfizer, travel accomodations from Roche, Astra Zeneca, Novartis, Lilly, MSD, Pfizer all outside the submitted work. AC, AL, CC, JB, SC, ACal, VM, RG, PT, EP, SV, GP, PDG, MG, FN, EC, AA, CLV report no COI to disclose.